Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-12

FDA Approved: ESTRING — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approves Pfizer's Supplemental Application for ESTRING (estradiol vaginal ring), updating labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRING (Estradiol)

Snippet

SUPPL AP for ESTRING (ESTRADIOL)